Dr. Nalini M. Guda, MD

Dr. Guda practices at Center for Digestive Health Ltd in Milwaukee, Wisconsin.

Dr. Guda's NPI, 1750358420, was assigned on March 2, 2006. Dr. Guda holds Wisconsin license 40326-020.

Dr. Guda's primary practice is Center for Digestive Health Ltd, at 2801 W Kinnickinnic River Pkwy, Milwaukee, WI 53215 in Milwaukee County. The practice phone is (414) 908-6500.

Dr. Guda's primary practice is Center for Digestive Health Ltd in Milwaukee, Wisconsin. Dr. Guda is also affiliated with Aurora St. Luke's Medical Center. The medical group on file is GI Associates. Dmand AI also links Dr. Guda to 2 more hospitals, 4 group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Guda practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Guda's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Guda is licensed in Wisconsin.

CMS data shows 850 Medicare services from Dr. Guda across 17 procedure codes in 2024, for 436 Medicare patients. Medicare paid $64,019 for them.

CMS counts 436 Medicare patients who saw Dr. Guda in 2024. The largest group is 65 to 74, with 212 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Guda's median patient age at 65, with 51% women.

In 2024, Dr. Guda wrote 924 Medicare Part D claims for 446 patients. 76% of them were for generic drugs. CMS names the drug for 788 of them, across 18 drugs with 11 or more claims each, at $273,191 in total drug cost. In 2023, CMS named 1,015 claims across 21 drugs.

Dr. Guda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 176 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Guda, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Guda in 2024. Dr. Guda's most frequent co-authors are Tyler M. Berzin, MD, Prabhleen Chahal, MD and Jonathan Cohen, MD.

CMS Open Payments shows 67 general payments to Dr. Guda from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Boston Scientific Corporation paid the most, $19,328. It also lists 1 research payment totaling $1,150 in 2022.